We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gary Zammit, PhD, President and Chief Executive Officer at Clinilabs. We often imagine medical breakthroughs as the result of data, protocols, and lab science alone. But Gary Zammit has seen firsthand that bringing therapies to patients requires far more: resilient teams, disciplined processes, and cultures that can weather setbacks. In his new book, Beyond the Science: How People, Process, and Systems Transform the Business of Life Sciences, Zammit offers readers an inside look at the real drivers of innovation. From navigating near-bankruptcy at Clinilabs to helping advance more than twenty therapies across thirteen CNS indications, his stories highlight the human and organizational forces that shape the future of medicine. Whether you are in healthcare, business leadership, or organizational strategy, Beyond the Science is both a practical guide and an urgent call to action: to build organizations as resilient and innovative as the science they support because patients are waiting. Check out the main topics of discussion for this episode of the Life Sciences Today podcast: Tell me about your journey. How did that shape you as a leader, and how did those experiences lead you to write Beyond the Science? From your vantage point at Clinilabs, what’s the most misunderstood people-or-process failure in drug development — and how does Clinilabs create value by solving it? How do you prove to sponsors that you’ve actually solved it? CROs often look interchangeable from the outside, yet Clinilabs has built a reputation in one of the most challenging therapeutic areas. Where does your defensibility — your ‘moat’ — really come from? What does Clinilabs do that sponsors or big site networks like Velocity Clinical can’t easily copy? In the closing of the book, you emphasize pushing beyond ‘good enough’ and building teams, systems, and processes that strive for greatness. Looking ahead 12–18 months, what are the three things you want to do for your customers that will raise the bar — things that will materially improve the way CNS trials get run? Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast. Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business. Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform: Apple Podcasts Spotify iHeartRadio Amazon Music Pandora YouTube Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn. If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes. Thanks so much for listening!
